FGFJ Publications | Launching a Pandemic Financing Facility: Three Proposals & Their Implications for the Global Fund
This Friends of the Global Fund, Japan publication documents proposed reforms to financing facilities for the Global Fund, with JCIE Senior Fellow Jim discussing the significance of these proposals for the Global Fund.
4th US-Japan Global Health Dialogue | Advancing Global Health Security and Future Pandemic Preparedness
The 4th US-Japan Global Health Dialogue brought together over 50 American and Japanese senior government officials, legislators, health experts, and leaders from international organizations to discuss ways that US-Japan collaboration can be leveraged to advance health security and pandemic preparedness globally. Participants discussed key issues in global health architecture, pandemic instruments and IHR, R&D including the 100 Days Mission, synergies between UHC and health security.
1st GFF Seminar | Introducing the Financing Facility
JCIE launched the GFF Seminar series in 2020 as part of its efforts to deepen understanding of how the Japanese government, NGOs, and others can coordinate more effectively with the GFF in order to strengthen maternal and child health and expand universal health coverage in the world’s most vulnerable countries.
Japan’s Global Health Strategy in the Post–COVID-19 Era Vol. 13 | The Significance and Challenges of Public-Private Partnership in Global Health Cooperation
This article examines the significance and challenges of public-private partnership in global health and explores multistakeholder relationships for effective global health cooperation in the post-COVID era.
Japan’s Global Health Strategy in the Post–COVID-19 Era Vol. 12 | Can the ACT Accelerator Achieve Truly Fair and Equitable Access to COVID-19 Tools?
This paper discusses ACT-A as a potential tool to ensure fair and equitable access to healthcare, through inclusive, democratic, and transparent decision making.
Japan’s Global Health Strategy in the Post–COVID-19 Era Vol. 6 | A Review of Challenges and Options for International Sharing of Pathogens and Related Information in Pandemic Response
This policy brief addresses the issues and options of international frameworks on sharing of pathogens and GSD based on the review of existing literature and other sources.
JCIE/USA Fellow and Board Members Featured in Special COVID Edition of Global Asia
“The COVID-19 pandemic has laid bare the lack of high-level political leadership in co-ordinating global action against the pandemic, with resultant failures in securing agreement between governments in support of common goals and alignment of efforts to tackle health, social and economic challenges. As a result, coherent global strategic directions in pandemic response have not […]
Global Health Diet Roundtable | Vaccine Diplomacy and Japan: What Is Needed Now?
On April 5, JCIE hosted its 6th Global Health Diet Roundtable, which was held online and attended by seven Diet members across multiple parties. Speakers discussed the current status of COVID-19 vaccine development around the world, background information on the vaccine development delays in Japan, and issues in the global COVID-19 response that Japan should address.
Global Health Diet Roundtable | Update on the Regional COVID-19 Situation
On April 21, JCIE held its Fifth Global Health Diet Roundtable where more than a dozen Diet members were briefed on the current global COVID-19 situation by World Health Organization (WHO) Western Pacific Regional Director, Takeshi Kasai. Dr. Kasai highlighted the importance of more well-thought-out testing strategies as well as the need for international cooperation on the global shortage of personal protective equipment (PPE).
Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security
On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joined the Special Session of the Executive Committee to explain how this unprecedented global health partnership is helping develop and equitably distribute critical COVID-19 tools.